NEW YORK (AP) – In a solid year for stocks, graphics processor maker Nvidia stood far above its peers on the Standard & Poor’s 500 index. The company’s stock more than tripled for the year. But it was far from the only company that made a notable move. Goldman Sachs helped a rally in financial companies and Caterpillar contributed to an industrial boom on Wall Street, while drug companies like Mylan suffered big drops.
CHIP CHIP, HOORAY
Nvidia’s stock jumped after each of its quarterly earnings reports, and the company was part of the big technology rally over the summer. Shares rose further in September when Nvidia said it will work with Baidu, a Chinese e-commerce company, to develop an autonomous driving system. Nvidia was also one of the biggest winners on the S&P 500 in 2015. Its shares ended 2012 at about $12 and traded above $100 at the end of 2016. It rose 238 percent and traded at all-time highs for most of the year.
DRUG STOCKS IN PAIN
Five of the 10 largest losses on the S&P 500 in 2016 went to drug companies. Endo International, the maker of Percocet, plunged 74 percent and reached 13-year lows. In February, the Irish drug and medical device maker said it will set aside $834 million to cover costs from possible product liability lawsuits related to its vaginal mesh implants, which have been linked to thousands of injuries. It also said it will wind down its Astora women’s health unit. In May the company disclosed a government inquiry into its relationships with pharmacy benefits management companies and also slashed its guidance. Many drug companies weakened as investors wondered if the federal government will take steps to reduce drug prices. Biotechnology companies like Alexion and Vertex took some steep losses.
